Acute lorazepam effects on neurocognitive performance

Epilepsy and Behavior

Volumn 25, Issue 3, 2012, Pages 329-333

  Loring, David W ^a   Marino, Susan E ^b   Parfitt, David ^c   Finney, Glen R ^c   Meador, Kimford J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aging; Antiepileptic drugs; Benzodiazepine; Cognition; Symptom validity measures

Indexed keywords

LORAZEPAM; PLACEBO;

ADULT; AGE; AGED; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; EPILEPTIC STATE; FEMALE; HUMAN; MALE; SINGLE DRUG DOSE; TASK PERFORMANCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTICONVULSANTS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LORAZEPAM; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; YOUNG ADULT;

EID: 84868702169     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.08.019     Document Type: Article

References (25)

1. Cumming R.G., Le Couteur D.G. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003, 17:825-837.
2. Ray W.A., Griffin M.R., Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989, 262:3303-3307.
3. Foy A., O'Connell D., Henry D., Kelly J., Cocking S., Halliday J. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol A Biol Sci Med Sci 1995, 50:M99-M106.
4. Rummans T.A., Davis L.J., Morse R.M., Ivnik R.J. Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients. Mayo Clin Proc 1993, 68:731-737.
5. Barbone F., McMahon A.D., Davey P.G., et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998, 352:1331-1336.
6. Meador K.J., Gevins A., Leese P.T., Otoul C., Loring D.W. Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam. Epilepsia 2011, 52:264-272.
7. Gualtieri C.T., Johnson L.G. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol 2006, 21:623-643.
8. Gualtieri C.T., Johnson L.G. Efficient allocation of attentional resources in patients with ADHD: maturational changes from age 10 to 29. J Atten Disord 2006, 9:534-542.
9. Green P. Green's word memory test for windows user's manual-revised 2005, Green's Publishing, Edmonton, Alberta.
10. Brown L., Sherbenou R.J., Johnsen S.K. Test of non-verbal intelligence 1996, Pro-Ed, Austin, TX. Third edition;TONI-3.
11. Brandt J. The Hopkins Verbal Learning Test: development of a new verbal memory test with six equivalent forms. Clin Neuropsychol 1991, 5:125-142.
12. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
13. Zhu H., Luo J. A fast and sensitive liquid chromatographic-tandem mass spectrometric method for assay of lorazepam and application to pharmacokinetic analysis. J Pharm Biomed Anal 2005, 39:268-274.
14. Guidance to industry: bioanalytical method validation [computer program] 2001, U.S Department of Health and Human Services, Rockville, MD.
15. Martin R., Meador K., Turrentine L., et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 2001, 42:764-771.
16. Pompéia S., Pradella-Hallinan M., Manzano G.M., Bueno O.F.A. Effects of lorazepam on visual perceptual abilities. Hum Psychopharmacol Clin Exp 2008, 23:183-192.
17. Marino S.E., Pakhomov S.V.S., Han S.H., et al. The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory. Epilepsy Behav 2012, 24:365-372.
18. Loring D.W., Williamson D.J., Meador K.J., Wiegand F., Hulihan J.F. Topiramate cognitive dose effects: a randomized double-blind study with reliable change indices. Neurology 2011, 76:131-137.
19. Cirulli E.T., Urban T.J., Marino S.E., et al. Genetic and environmental correlates of topiramate-induced cognitive impairment. Epilepsia 2012, 53:e5-e8.
20. Meador K.J., Loring D.W., Huh K., Gallagher B.B., King D.W. Comparative cognitive effects of anticonvulsants. Neurology 1990, 40:391-394.
21. Li K.Z., Lindenberger U., Freund A.M., Baltes P.B. Walking while memorizing: age-related differences in compensatory behavior. Psychol Sci 2001, 12:230-237.
22. Nyberg L., Nilsson L.-G., Olofsson U., Bäckman L. Effects of division of attention during encoding and retrieval on age differences in episodic memory. Exp Aging Res 1997, 23:137-143.
23. Gaudreau J.-D., Gagnon P., Harel F., Roy M.-A., Tremblay A. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005, 23:6712-6718.
24. Alldredge B.K., Gelb A.M., Isaacs S.M., et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345:631-637.
25. Cereghino J.J. Identification and treatment of acute repetitive seizures in children and adults. Curr Treat Options Neurol 2007, 9:249-255.